C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/11 (2006.01) A61K 31/429 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2668346
The present invention provides methods, reagents, pharmaceutical formulations and kits for the treatment of proliferative diseases, such as tumours and cancers. The invention teaches to target select subunits of the Na+,K+-ATPase, and especially the alpha-1 subunit and/or the alpha-3 subunit thereof.
L'invention propose des procédés, des réactifs, des formulations pharmaceutiques et des coffrets pour le traitement de maladies prolifératives, telles que les tumeurs et les cancers. L'invention propose de cibler des protomères sélectionnés de la Na+, K+-ATPase, et, en particulier, le protomère alpha-1 et/ou le protomère alpha-3 de celle-ci.
Darro Francis
Deneve Nancy
Kiss Robert
Mijatovic Tatjana
Van Den Hove Laurent
Smart & Biggar
Unibioscreen S.a.
LandOfFree
Targeting of alpha-1 or alpha-3 subunit of na+, k+-atpase in... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Targeting of alpha-1 or alpha-3 subunit of na+, k+-atpase in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Targeting of alpha-1 or alpha-3 subunit of na+, k+-atpase in... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1749289